**Chapter 11**

*Oral Diseases*

[31] Zhang J, Zhang Q, Zhang Q, Liu XK, Li CQ, Guo ZM. Expression and clinical significance of SPARC in clinical stage II tongue squamous cell carcinoma. Ai Zheng. 2009;**28**(1):68-71 Kowalski LP. Expression of vascular endothelial growth factor-C does not predict occult lymph-node metastasis in early oral squamous cell carcinoma. International Journal of Oral and Maxillofacial Surgery.

[38] Hanakawa H, Orita Y, Sato Y, Takeuchi M, Takao S, Ohno K, et al. Does HMGB1 predict occult neck lymph node metastasis in early tongue carcinoma? A case–control study of 26 patients. The Journal of Laryngology and Otology. 2014;**128**(10):926-931

[39] Parikh AS, Puram SV,

2019;**99**:104458

2016;**130**(S2):S161-S169

Faquin WC, Richmon JD, Emerick KS, Deschler DG, et al. Immunohistochemical

[40] Paleri V, Urbano TG, Mehanna H, Repanos C, Lancaster J, Patel M, et al. Management of neck metastases in head and neck cancer: United Kingdom National Multidisciplinary Guidelines. The Journal of Laryngology & Otology.

quantification of partial-EMT in oral cavity squamous cell carcinoma primary tumors is associated with nodal metastasis. Oral Oncology.

2008;**37**(4):372-378

[32] Huber GF, Züllig L, Soltermann A, Roessle M, Graf N, Haerle SK, et al. Down regulation of E-cadherin (ECAD)—A predictor for occult metastatic disease in sentinel node biopsy of early squamous cell carcinomas of the oral cavity and oropharynx. BMC Cancer. 2011;**11**:1-8.

DOI: 10.1186/1471-2407-11-217

[33] Huber GF, Fritzsche FR,

2011;**129**(6):1404-1409

[35] Mäkinen LK, Häyry V,

Keski-Säntti H, et al. Matrix metalloproteinase-7 and matrix metalloproteinase-25 in oral tongue squamous cell carcinoma. Head & Neck.

[36] Kelner N, Rodrigues PC, Bufalino A, Fonseca FP, dos Santos-Silva AR, Miguel MCC, et al. Activin A immunoexpression as predictor of occult lymph node metastasis and overall survival in oral tongue squamous cell carcinoma. Head

& Neck. 2014;**37**(4):479-486

[37] Faustino SES, Oliveira DT,

Nonogaki S, Landman G, Carvalho AL,

2014;**36**(12):1783-1788

Züllig L, Storz M, Graf N, Haerle SK, et al. Podoplanin expression correlates with sentinel lymph node metastasis in early squamous cell carcinomas of the oral cavity and oropharynx. International Journal of Cancer.

[34] Sonali P, Vasudeva G, Charlotte SM. Association of the co-expression of SOX2 and Podoplanin in the progression of oral squamous cell carcinomas—An immunohistochemical study. Journal of Applied Oral Science [Internet]. 2019;**27**:e20180348. [Cited: 17 November

Hagström J, Sorsa T, Passador-Santos F,

**140**

2019]
